Logo do repositório
 
Publicação

Innervis: launching a startup to commercialize central nervous system targeted antiviral therapies- strategic and operational development and intellectual property protection strategies

2026-01-07Dissertação de mestrado Acesso embargado
Ver registo simples
authorProfile.emaildrodpereira@gmail.com
datacite.subject.fosCiências Sociais::Economia e Gestão
dc.contributor.advisorOliveira, Nuno Arantes de
dc.contributor.authorPereira, Duarte Martinho Rodrigues
dc.date.accessioned2026-04-16T13:39:09Z
dc.date.available2026-04-16T13:39:09Z
dc.date.issued2026-01-07
dc.date.submitted2026-01-07
dc.description.abstractNeurotropic viruses like Zika, Dengue, HIV, and SARS-CoV-2 infiltrate the central nervous system, causing irreversible brain damage and congenital defects. Nevertheless, current antivirals have limited effectiveness in crossing the blood-brain barrier. Innervis, under an exclusive license from the Gulbenkian Institute for Molecular Medicine (GiMM), develops Peptide-Porphyrin Conjugates (PPCs) that overcome these barriers and neutralize viruses in neural tissue. This business plan outlines the strategy to establish a pipeline into the drug development market, covering IP creation, operational execution, potential partnerships, funding needs and sources, and valuation scenarios that build a clear roadmap to a pharmaceutical acquisition.eng
dc.identifier.tid204237548
dc.identifier.urihttp://hdl.handle.net/10362/202294
dc.language.isoeng
dc.relationUID/ECO/00124/2013
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectStrategy
dc.subjectEntrepreneurship
dc.subjectIntrapreneurship
dc.subjectInternational business
dc.subjectM&A
dc.subjectVenture capital
dc.subjectFund raising
dc.subjectTechnology strategy
dc.subjectIntellectual property
dc.subjectOperations management
dc.subjectStartup
dc.subjectBiotech
dc.subjectTherapeutics market
dc.subjectManagement
dc.subjectFinancials
dc.subjectCost structure
dc.subjectOperations
dc.subjectValuation
dc.subjectExit strategy
dc.subjectFunding
dc.titleInnervis: launching a startup to commercialize central nervous system targeted antiviral therapies- strategic and operational development and intellectual property protection strategieseng
dc.typemaster thesis
dspace.entity.typePublication
thesis.degree.nameA Work Project, presented as part of the requirements for the Award of a Master’s degree in Management and Impact Entrepreneurship and Innovation from the Nova School of Business and Economics

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
Innervis_Launching_a_Startup_to_Commercialize_Central_Nervous_System_Targeted_Antiviral_Therapies_Strategic_and_Operational_Development_and_Intellectual_Property_Protection_Strategies.pdf
Tamanho:
862.43 KB
Formato:
Adobe Portable Document Format
Ver/Abrir
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
348 B
Formato:
Item-specific license agreed upon to submission
Descrição:
Ver/Abrir

Coleções

NSBE - Management